Abstract
dc:description.abstractThe aim of this work was to develop tri-modal cell labels for tracking immune cells \(in\) \(vivo\), particularly for longitudinal studies of immune cell therapies. Localisation and quantification of the cells is invaluable in determining the effectiveness of these treatments, so imaging agents for fluorescence, 1H MRI and 19F MRI were combined. Four combinations of agents in a robust scaffold were investigated: luminescent dyes and a 1H MRI contrast agent were trapped electrostatically in a silica matrix; luminescent dyes and proton MRI agents were bound to silica and gold nanoparticle surfaces; fluorinated fluorescent dyes were investigated briefly; and all three modalities’ agents were combined by filling and functionalising a silica shell. All of these combinations were characterised and imaged using a clinical 3T MRI scanner. Lead compounds from each section were incubated with white blood cells, examining uptake in monocytes and lymphocytes, with preliminary observations of viability. Detection of labelled cells by their luminescence and MRI contrast enhancement was possible in some cases, though 19F MRI still poses some challenges. Detection limits by 19FMRI were determined for a range of fluorinated compounds, elucidating the possibilities of translating 19F MRI into the clinic with current technology.
Degree
thesis:*- Name dc:type.qualificationname
- d_ph
- Level dc:type.qualificationlevel
- d_ph
- Grantor dc:publisher.institution
- University of Birmingham
- Year dc:date.issued
- 2016
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- van Gemeren, Lindsey
Subjects
dc:subject × 3Rights
- Language dc:language.dcterms_iso639_2
- eng